Kenvue (KVUE) Stock News

Kenvue (NYSE: KVUE), known for brands like Tylenol, Neutrogena, and Listerine, has achieved a significant milestone by making its debut on the Fortune 500 list at position 281, with annual sales of $15.5 billion in 2024. As a newly independent company, Kenvue operates in over 165 countries with a workforce of 20,000 employees, reaching approximately 1.2 billion consumers daily through its Essential Health, Self Care, and Skin Health & Beauty brands. CEO Thibaut Mongon highlighted this achievement as validation of the company's dedication and progress toward becoming the global leader in consumer health. The company focuses on combining scientific expertise with human insights and advanced technology to advance its wellness mission.

Kenvue Inc. (NYSE: KVUE), known for brands like Neutrogena®, Listerine®, Aveeno®, and Tylenol®, has announced its participation in the Deutsche Bank's dbAccess Global Consumer Conference in Paris, France. The company's leadership team, including CEO Thibaut Mongon, CFO Amit Banati, and Group President Carlton Lawson, will engage in a fireside chat on June 3, 2025, at 6:00 a.m. ET / 12:00 p.m. CET. Investors can access a live webcast of the session on investors.kenvue.com, with a replay available after the event.

Kenvue (NYSE: KVUE) has announced its global Kenvue Cares Week initiative, showcasing significant community engagement across 21 markets on six continents. The company's employees, known as Kenvuers, are contributing over 5,000 volunteer hours and assembling approximately 22,000 hygiene kits containing more than 110,000 products from brands like Neutrogena®, Listerine®, and Johnson's® Baby.

The program, which has seen a fourfold increase in site participation since its inaugural year, involves partnerships with organizations like Save the Children, Heart to Heart International, and various local nonprofits. Activities include disaster relief efforts, environmental initiatives, and community support programs across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific regions.

Kenvue (NYSE: KVUE) reported its Q1 2025 financial results, showing a 3.9% decrease in net sales and 1.2% decline in organic sales. The company's performance was impacted by foreign currency headwinds of 2.7%. Key financial metrics include: • Gross profit margin increased to 58.0% from 57.6% • Operating income margin rose to 14.9% from 14.1% • Diluted EPS improved to $0.17 from $0.15 • Adjusted diluted EPS decreased to $0.24 from $0.28 For FY2025, Kenvue updated its outlook to reflect foreign exchange rates and tariff impacts, projecting: • Net sales growth of +1% to +3% • Organic sales growth of +2% to +4% • Expected decline in adjusted operating income margin • Adjusted diluted EPS to remain flat year-over-year

Kenvue (NYSE: KVUE) has appointed Amit Banati as its new Chief Financial Officer, effective May 12, 2025. Banati, a 30-year veteran in consumer products finance and operations, will succeed Paul Ruh and oversee Finance and Strategy functions. Banati joins from Kellanova (previously Kellogg Company) where he served as Vice Chairman and CFO, with prior experience at Kraft Foods, Cadbury Schweppes, and Procter & Gamble.

The new CFO brings significant international operations experience, particularly in Asia Pacific, Middle East, India, and Africa. His focus will be on supporting revenue growth through data management, resource allocation, margin improvement, strengthening cash flow, and fostering greater agility in business planning and financial forecasting.

Kenvue (NYSE: KVUE), the world's largest pure-play consumer health company by revenue, has scheduled its first quarter 2025 financial results announcement for May 8, 2025, before market open. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results.

Investors can access the conference call by dialing 877-407-8835 (U.S.) or +1 201-689-8779 (international). A live webcast will be available at investors.kenvue.com, with a replay accessible after the event.

Kenvue's portfolio includes renowned brands such as Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena, and Tylenol, which are science-backed and recommended by healthcare professionals globally.

Kenvue (NYSE: KVUE) has announced a quarterly dividend declaration approved by its Board of Directors. The company will pay a dividend of $0.205 per share on its common stock. The dividend will be distributed on May 28, 2025, to shareholders who are recorded on the company's books at the close of business on May 14, 2025.

Kenvue Inc. (NYSE: KVUE), the world's largest pure-play consumer health company, has announced a five-year collaboration with Microsoft to transform its digital operations through advanced AI technologies. The partnership will leverage Microsoft Azure's capabilities in machine-enabled collaboration, predictive analytics, smart agents, digital twins, and generative AI.

The collaboration aims to:

• Accelerate product development and optimize clinical research data
• Advance data-driven market strategies and personalize consumer experiences
• Enhance retail excellence through algorithmic selling and improved inventory management
• Optimize business processes for new growth opportunities

Kenvue is already piloting Microsoft Azure AI, Microsoft 365 Copilot, and Copilot Studio integration across supply chain, operations, and content creation functions.

Kenvue Inc. (NYSE: KVUE) has announced actress and entrepreneur Shay Mitchell as the first global brand ambassador for OGX® Haircare. Mitchell will represent the brand's Fixer character in a new 360° campaign promoting the OGX® Bond Protein Repair line.

The campaign features Mitchell alongside Trichologist Abbey Yung, highlighting solutions for hair damage through television spots and a #DamageDetected social media series. The new product line includes a Bond Protein Repair 450°F Heat Protect Spray, formulated with a patented bond-building protein to repair and protect hair at a lower price point than salon brands.

According to Andrew Stanleick, President of Skin Health & Beauty at Kenvue, 8 in 10 people experience hair damage. The campaign aims to address these concerns with science-backed repair solutions. OGX® currently holds the position of #1 in hair repair based on market data through November 2024.